Kwality Pharmaceuticals Ltd reports Q2FY27 consolidated revenue of ₹181.22 crore, up 63.2% YoY, and net profit of ₹29.03 crore
- EBITDA margin was 27.5%; revenue rose 11.6% sequentially and net profit increased 105.8% YoY.
- Management discussion cites Q2 PAT of ₹50 crore, differing from the consolidated results table; no quarterly exceptional items were reported.
- Board noted Vijay Mehra & Co.’s resignation effective November 12 and approved B S R & Co. LLP as replacement, subject to member approval.
